← FDA Drug Approvals (Drugs@FDA)

ZOLMITRIPTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2016-12-01

Drug application

FDA Application #

ANDA205074

Application type

Abbreviated New Drug Application (Generic)

Brand name

ZOLMITRIPTAN

Generic name

ZOLMITRIPTAN

Active ingredients

ZOLMITRIPTAN

Dosage form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2016-12-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown